Health TrialsbyHealthPanel

The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

ConditionSensitive Skin
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorShanghai Dermatology Hospital

About this trial

The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Sensitive skin with a diagnosis of persistent erythema and a lactate irritation test score of 2-3

No related skin care products including bovine alkaline fibroblast growth factor were used within 1 month before participating in the experiment, and photoelectric treatment measures were not carried out

Physical sunscreen should be strict during enrollment

Disqualifiers

Children

Have serious heart, liver, kidney, and blood system diseases, and severe immunocompromise

Patients with mental illness or cancer

Those who have received glucocorticoids, calcineurin inhibitors, topical small molecule drugs, antibiotics or tretinoin within 3 months

Trial design

Design model

Single group

Treatments tested in this trial

  • bFGF

    Drug

    Half-face randomized control

  • Bovine Basic Gel

    Drug

    Bovine Basic Gel

Treatment groups

28 Participants
are divided into 2 treatment groups
Group A: The Application of Bovine Basic Fibroblast Growth Factor GelExperimental treatment 1 intervention
Group B: Bovine Basic GelPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

erythema index

The change rate in lesion clearance of face at 1 month after treatment will be measured as the primary outcome

Time frame
0、1、2、4 week

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Shanghai Dermatology Hospital

Lead sponsor

Source ClinicalTrials.gov
Apply now